Interventional and synthetic therapy of advanced hepatocellular carcinoma / 中华医学杂志(英文版)
Chinese Medical Journal
;
(24): 1883-1885, 2002.
Artigo
em Inglês
| WPRIM
| ID: wpr-356886
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the clinical efficacy of interventional therapy in the treatment of hepatocellular carcinoma (HCC).</p><p><b>METHODS</b>Thirty-three patients with HCC were synthetically treated by systematic measures. Among them, percutaneous port-catheter system (PCS) implantation via the femoral artery was performed in 21 cases. Patients with haemorrhage were treated with prothrombin complex concentrate and fibroraas, and patients with hepatic encephalopathy by branched-chain amino acids and arginine.</p><p><b>RESULTS</b>All indwelling catheters of PCS were patent and no catheter tip dislocations were observed. Of 33 patients with advanced HCC, the mean survival rate was 20.1 months and 12 (36%) patients survived more than 2 years.</p><p><b>CONCLUSION</b>Patients with advanced HCC were treated by synthetic measures. Survival was prolonged, quality of life was improved significantly, and the effectiveness of interventional therapy was further improved.</p>
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Terapêutica
/
Cateteres de Demora
/
Taxa de Sobrevida
/
Mortalidade
/
Carcinoma Hepatocelular
/
Neoplasias Hepáticas
Tipo de estudo:
Estudo prognóstico
Limite:
Adulto
/
Idoso
/
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Chinese Medical Journal
Ano de publicação:
2002
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS